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Abstract  
Viral hepatitis during pregnancy is associated with high risk of maternal complications and has become a leading cause of fetal death. So the main 
objective of this study is to determine the prevalence of hepatitis C viral infections among pregnant women attending the antenatal clinic in Bahir 
Dar health institutions, Ethiopia. This was institutional based cross-sectional study that included 318 pregnant women who attended the antenatal 
clinic in Bahir Dar health institutions from January 2013 to June 2013. Appropriate data was gathered from study participants. Sero-prevalence of 
hepatitis C virus was determined by detecting immunoglobulin of HCV using ELISA kit. Data was entered and analyzed with SPSS version 16 
statistical software. The overall prevalence of hepatitis C virus among pregnant women was 0.6%. None of the expected risk factors had significant 
outcome. In conclusion, prevalence of the Hepatitis C virus among pregnant women attending in Bahir Dar health institutions was low and 
expected variables were not statistically significant. 
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Hepatitis viruses are the main cause of liver cancer. Among those, 
hepatitis C virus is the one that causes hepatocellular carcinoma. It 
can be ended with development of cirrhosis and hepatocellular 
carcinoma (HCC). Moreover infection with HBV and HCV affects the 
liver and results in a broad spectrum of disease outcome [1, 2].  
  
World health organization estimated that approximately 170 million 
people are infected with HCV, about 130 million are carriers, three 
to four million persons are newly infected in each year and more 
than 350,000 people estimated to die from hepatitis C-related liver 
diseases in each year worldwide [3]. The worldwide prevalence of 
hepatitis C virus (HCV) infection in pregnant women is estimated to 
be between 1 and 8% and in children between 0.05% and 5% [4].  
  
Data from the adult population suggest that approximately 10–20% 
of patients with HCV can go on to develop cirrhosis and 
hepatocellular carcinoma and the probability of becoming a chronic 
carrier is inversely related to age at the time of infection [5]. The 
prevention of vertical transmission is very important, because 
infection at infancy usually leads to a chronic carrier status [6]. 
Some of the risk factors for contracting HCV include sharing of 
injecting equipment, tattooing or piercing with unsterile equipment 
or procedures, working in environments where there is contact with 
bodily fluids, receiving blood transfusions, receiving dialysis, 
surgery, sharing of equipment with a person having HCV, practicing 
unsafe sex or having contact with blood without adequate 
protection [7, 8].  
  
Even though some studies on sero-prevalence of HCV infection in 
Ethiopia have been previously done and indicated as it is endemic in 
Ethiopia with regional variation [9], no data about the prevalence of 
hepatitis C virus among pregnant women are available in Bahir Dar 
city administration. The present study was conducted to determine 
the prevalence of hepatitis C virus among pregnant women and to 





Study design, period and area  
  
Institutional based cross sectional study was carried out from 
January 2013 to June 2013 to assess the sero- prevalence and 
associated risk factors of Hepatitis C viruses among pregnant 
women attending antenatal care in Bahir Dar health institutions, 
Bahir Dar town. Bahir Dar is the capital of the Amhara regional state 
and situated on the southern shore of Lake Tana, the source of the 
Blue Nile. It is located approximately 578 km northwest of Addis 
Ababa, having a latitude and longitude of 11°36'N 37°23'E 
Coordinates and an elevation of 1840 meters above sea level. Based 
on the 2007 Census conducted by the Central Statistical Agency of 
Ethiopia (CSA), Bahir Dar Special Zone has a total population of 
221,991, of whom 108,456 are men and 113,535 women; 180,174 
or 81.16% are urban inhabitants, the rest of population are living at 
rural kebeles around Bahir Dar. From the town there is one 
governmental referral hospital (FelegeHiwot hospital) and 10 
governmental health centers. The hospital and 3 randomly selected 
health centers (Bahir Dar health centers, Han health centers and Tis 
Abay health centers) were included as our study sites.  
  
Population and sample size determination  
  
The source population was all pregnant women who have access to 
attend antenatal care from Bahir Dar health institutions, whereas 
the study population was all pregnant women who attended 
antenatal care from the selected health institutions during the study 
period. The study subjects were also all pregnant women who 
attended antenatal care at the selected health institutions during 
data collection time that fulfill the inclusion criteria and signed the 
consent form. The single population proportion formula was used to 
determine the sample size and accordingly 318 study subjects were 
included in this study. The number of sample size in each of the 
selected study sites was proportionally allocated and convenient 
sampling technique was used until the sample size completed.  
  
Data collection  
  
Administration of questioners  
  
A pretested structured questionnaire was used to collect socio-
demographic characteristics and other expected risk factors of the 
clients. The data collectors were trained laboratory 
technologist/technician and nurses.  
  
Sample collection and laboratory investigation  
  
About 5ml of whole blood sample was drawn through vein-puncture, 
and serum was separated and stored in a refrigerator in the study 
area. The collected samples from the study sites was taken into the 
place where the laboratory investigation takes place. Sero-
prevalence of hepatitis C virus was determined by detecting 
immunoglobulin of HCV using ELISA kit based on the manufacturer’s 
instruction. Positive results were retested again with ELISA.  
  
Quality control  
  
The questionnaire was pretested at the health center other than the 
actual study sites. The collected data was daily checked for 
consistency and accuracy. Standardized procedures was strictly 
followed at each of pre-analytical, analytical and post analytical 
process. Positive and negative controls were run alongside the test.  
  
Data processing and analysis  
  
Data was entered and analyzed using SPSS Version 16.0 statistical 
software. Binary logistic regression was done to determine the 
presence of a statistically significant association between 
explanatory variables and the outcome variables. Odds Ratio (OR), 
p-value and their 95% Confidence Intervals (CI) was calculated.  
  
Ethical considerations  
  
The study was conducted after obtaining institutional ethical 
clearance from ethical review committee of College of Medicine and 
Health Sciences, Bahir Dar University. Verbal consent was also 
obtained from the study participants. Positive results was reported 
to their physicians for the treatment and any antenatal care. 
Confidentiality was maintained and the clinical specimen collected 





Demographic characteristics  
  
A total of 318 pregnant women was included in this study. The 
mean age of the study participants was 25.72 (SD. ±5.14) years 
Page number not for citation purposes 3 
old. Among the total number of participants, 214 (67.3%) were 
living in an urban setting. The majority of the study participants 
were housewives (56.9%). One hundred twenty five (39.3%) of the 
participants did not attend formal education.  
  
Prevalence of HCV  
  
Among 318 pregnant women, 2 (0.6%) were confirmed as HCV 
positive. All of HCV positive pregnant women were among orthodox 
religion followers, married and on secondary trimester. None of the 
expected risk factors (history of blood transfusion, dental 
manipulations, tattooing circumcision etc. and other socio-
demographic factors) had been found to be associated with HCV 





Infections due to Hepatitis C viruses (HCV) is significant health 
problems around the globe. Worldwide, viral hepatitis is the 
commonest cause of hepatic dysfunction in pregnancy. In our study, 
the frequency of Hepatitis C virus infections among pregnant 
women attending antenatal care in Bahir Dar health institutions was 
0.6%. This was similar to the study which was conducted from 
Sudan, (0.6%) [10]. All of the HCV positive pregnant women were 
among secondary trimesters and orthodox religion followers.  
  
In contrast the prevalence of HCV in our finding was less than the 
studies conducted from Nigeria (3.6%) [11], Cameron (1.9%) [12], 
Egypt (6.4%) [13] and Gondar, Ethiopia (1.3%) [14]. These 
discrepancies might not be disparate with the fact that some of the 
studies were not from the same risk group and some of the them 
were done with the detection of both hepatitis C virus RNA and anti 
HCV antibody, which was Anti HCV antibody detection only in case 
of our study. This may loss the acute infections before antibody 
production.  
  
None of the expected risk factors (history of blood transfusion, 
sugery, dental manipulations, tattooing circumcision etc. and other 
socio-demographic factors) for sero-positivity of HCV had been 
identified in the study. This might be due to the small sample size 
we used. Moreover in similar studies reported at Nigeria and Sudan, 
these expected risk factors were not associated for the positivity of 
HCV [10,11]. The explanations for such observations need to be 





The frequency of hepatitis C virus in this study was low. None of the 
expected risk factors for sero-positivity of HCV had been also 
identified in the study. There is a need of further study on large 












YZ: Contributed from inception of the research question to design, 
analysis, interpretation and preparation of the manuscript. BA: 
contributed to proposal development, data analysis and manuscript 
writing, WM, MY: participated in proposal development, analyzed 
the data, edit and write the manuscript. All authors read and 





We are glad to Bahir Dar University, for granting this study. We also 
express our appreciation to Bahir Dar health institution maternal 
health care workers who helped us on data collection and delivering 





Table 1: prevalence of HCV among pregnant women attending 
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Socio-demographic variables   HCV 
Positive, N (%) Negative, N (%) 
Residence   
Urban 1 (0.5) 213 (99.5) 
Rural 1 (1.0) 103 (95.2) 
Age groups (yrs.)   
<21 0 (0.0) 81 (100.0) 
21-24 0 (0.0) 84 (100.0) 
25-30 1 (0.9) 108 (99.9) 
>30 1 (2.3) 43 (97.7) 
Religion   
Orthodox 2 (0.7) 272 (99.3) 
Muslim 0 (0.0) 40 (100.0) 
Protestant 0 (0.0) 4 (100.0) 
Occupation   
Merchant 1 (2.4) 41 (97.6) 
Student 0 (0.0) 18 (100.0) 
Housewife 1 (0.6) 180 (99.4) 
Day laborer 0 (0.0) 16 (100.0) 
Employer 0 (0.0) 35 (100.0) 
Others 0 (0.0) 26 (100.0) 
Educational status   
Not literate 1 (0.8) 124 (99.2) 
Primary level 0 (0.0) 79 (100.0) 
Secondary level 0 (0.0) 59 (100.0) 
Diploma and above 1 (1.8) 54 (98.2) 
Marital status   
Unmarried 0 (0.0) 15 (100.0) 
Married 2 (0.7) 294 (99.3) 
Divorced 0 (0.0) 6 (100.0) 
Widowed 0 (0.0) 1 (100.0) 
Average monthly income (Birr)   
<1000 1 (0.8) 118 (99.2) 
1000-1500 0 (0.0) 64 (100.0) 
1501-2300 0 (0.0) 58 (100.0) 




10  trimester 0 (0.0) 60 (100.0) 
20  trimester 2 (1.4) 139 (98.6) 
30  trimester 0 (0.0) 117 (100.0) 
 
 
 
